Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage Patient Counseling Information MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Indications/Uses

Brexpiprazole (Rexulti) is indicated for: Adjunctive treatment of major depressive disorder (MDD) in adults [see Pharmacology: Pharmacodynamics: Clinical Studies: Adjunctive Treatment of Major Depressive Disorder under Actions].
Treatment of schizophrenia in adults and pediatric patients ages 13 years and older [see Pharmacology: Pharmacodynamics: Clinical Studies: Schizophrenia under Actions].
Treatment of agitation associated with dementia due to Alzheimer's disease.
Limitations of Use: Rexulti is not indicated as an as needed ("prn") treatment for agitation associated with dementia due to Alzheimer's disease [see Pharmacology: Pharmacodynamics: Clinical Studies: Agitation Associated with Dementia Due to Alzheimer's Disease under Actions].

Rexulti Indications/Uses

brexpiprazole

Manufacturer:

Otsuka (Philippines)

Distributor:

Otsuka (Philippines)